Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis

被引:66
|
作者
Tanriverdi, Sakine Tuncay [1 ]
Ozer, Ozgen [1 ]
机构
[1] Ege Univ, Fac Pharm, Dept Pharmaceut Technol, TR-35100 Izmir, Turkey
关键词
Liposome; Ethosome; Ungual delivery; Terbinafine; HUMAN NAIL PLATE; IN-VIVO; DRUG-DELIVERY; SKIN DELIVERY; PERMEATION; LIPOSOMES; PERMEABILITY; PENETRATION; VITRO; GEL;
D O I
10.1016/j.ejps.2012.12.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Terbinafine hydrochloride (TBF-HCl) is an active substance that is using for treatment of onychomycosis. Onychomycosis is a fungal infection which is the most common disease of nail plate. The nail plate is a barrier which prevents effective topical treatment of ungual disorders. In this study, TBF-HCl loaded liposome and ethosome formulations and also gel form of these formulations were prepared. The formulations were characterized and in vitro and ex vivo release studies were performed. Nail characterization studies were also performed to examine the effect of formulations and experimental conditions on nail surface. As a result, all formulations can serve as efficient formulations for ungual application of TBF-HCl. By the way, the results of the accumulation studies suggested that liposome poloxamer gel formulation could be promising system for ungual drug delivery due to the better accumulation and easier application of the formulation. (C) 2012 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:628 / 636
页数:9
相关论文
共 50 条
  • [21] Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis
    Dominicus, R.
    Weidner, C.
    Tate, H.
    Kroon, H-A
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (06) : 1360 - 1362
  • [22] Terbinafine nail solutions for topical treatment of onychomycosis: Ex vivo study on penetration/retention through and into keratin membranes
    Monti, Daniela
    Mailland, Federico
    Chetoni, Patrizia
    Tampucci, Silvia
    Burgalassi, Susi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB109 - AB109
  • [23] The Plant Defensin Ppdef1 Is a Novel Topical Treatment for Onychomycosis
    van der Weerden, Nicole L.
    Parisi, Kathy
    Mckenna, James A.
    Hayes, Brigitte M.
    Harvey, Peta J.
    Quimbar, Pedro
    Wevrett, Sean R.
    Veneer, Prem K.
    Mccorkelle, Owen
    Vasa, Shaily
    Guarino, Rosemary
    Poon, Simon
    Gaspar, Yolanda M.
    Baker, Michael J.
    Craik, David J.
    Turner, Rob B.
    Brown, Marc B.
    Bleackley, Mark R.
    Anderson, Marilyn A.
    JOURNAL OF FUNGI, 2023, 9 (11)
  • [24] Drug evaluation: AN-2690, a novel antifungal for the topical treatment of onychomycosis
    Barak, Orr
    Loo, Daniel S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (08) : 662 - 668
  • [25] A novel topical 2% formulation of miconazole demonstrates potential in the treatment of onychomycosis
    Ghannoum, Mahmoud
    Isham, Nancy
    Catalano, Veronica
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB115 - AB115
  • [26] TERBINAFINE: NOVEL FORMULATIONS THAT POTENTIATE ANTIFUNGAL ACTIVITIES
    Ma, Y.
    Chen, X.
    Guan, S.
    DRUGS OF TODAY, 2015, 51 (03) : 197 - 208
  • [27] Itraconazole versus terbinafine (LAMISIL®):: which is better for the treatment of onychomycosis?
    Honeyman, JF
    Talarico, S
    Arruda, LHF
    Pereira, AC
    Santamaria, JR
    Souza, EM
    Woscoff, A
    Amorim, R
    De la Parra, CR
    Enokihara, MY
    Gavazoni, MF
    Gubelin, HW
    Rosa, SP
    Turini, MAG
    Vitale, MA
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1997, 9 (03) : 215 - 221
  • [28] TOPICAL AND SURGICAL-TREATMENT OF ONYCHOMYCOSIS
    COHEN, PR
    SCHER, RK
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (03) : S74 - S77
  • [29] A financial perspective on the topical treatment of onychomycosis
    Lagrew, James Prewitt
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (01) : E37 - E37
  • [30] Pharmacoeconomic assessment of ciclopirox topical solution, 8%, oral terbinafine, and oral itraconazole for onychomycosis
    Gupta, Aditya K.
    Lynde, Charles W.
    Barber, Kirk
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2006, 10 : S54 - S62